|
Volumn 101, Issue 7, 2007, Pages 633-634
|
The treatment of severe malaria
|
Author keywords
Antimalarials; Artesunate; Mortality; Severe malaria; Suppositories; Treatment
|
Indexed keywords
ANTIMALARIAL AGENT;
ARTEMETHER;
ARTEMISININ DERIVATIVE;
ARTESUNATE;
CHLOROQUINE;
QUININE;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BRAIN MALARIA;
CLINICAL TRIAL;
DEVELOPING COUNTRY;
DISEASE SEVERITY;
DRUG ABSORPTION;
FLUID RESUSCITATION;
GOOD MANUFACTURING PRACTICE;
HEALTH CARE AVAILABILITY;
HEALTH CARE FACILITY;
HUMAN;
HYPOVOLEMIA;
INTENSIVE CARE;
MALARIA FALCIPARUM;
META ANALYSIS;
MORTALITY;
PARASITE TRANSMISSION;
REVIEW;
RISK REDUCTION;
RURAL HEALTH CARE;
SECOND TRIMESTER PREGNANCY;
SUPPOSITORY;
SYSTEMATIC REVIEW;
THIRD TRIMESTER PREGNANCY;
TIME;
ADULT;
AFRICA;
ANTIMALARIALS;
ARTEMISININS;
ASIA;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
MALARIA, FALCIPARUM;
PREGNANCY;
QUININE;
RANDOMIZED CONTROLLED TRIALS;
SESQUITERPENES;
SUPPOSITORIES;
ARTESUNATE;
|
EID: 34248142148
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/j.trstmh.2007.03.011 Document Type: Review |
Times cited : (29)
|
References (5)
|